Non substitutables, or "branded" generics do always require clinical trials. It's not the FDA that differentiates, it's the sponsor. They intentionally file as a brand as a business strategy. It's generally been a tough strategy to gain traction since by definition they're competing against generics.
Market Data 
Markets 
AI
